Impact your Diabetes Patient Population

April 4, 2019

Boost Your Type 2 Diabetes Management With These Diagnostic Devices & Management Solution.

The prevalence of Type 2 Diabetes is 3 to 7 times higher in those suffering from obesity. Over 80 million American adults also suffer from pre-diabetes with 90% of those unaware of their health risks.

That's why The Center for Medical Weight Loss (CMWL) is offering a special bundled solution of diagnostic devices and treatment tools. Make your practice a powerful center for diabetic care.

What's inside:

1.Autonomic Nervous System Testing

  • $10-$20K additional monthly revenue
  • $350 (Medicare, Commercial)
  • Any staff member easily trained
  • Consists of plethysmography, Ankle Brachial Index (ABI), Heart Rate Variability (HRV), Cardiac Autonomic Reflex Tests (CARTs), Blood Pressure and arterial stiffness analysis and Sudomotor function.

2. Diabetic Neuropathy Device (DND)

  • $100K in profitability per provider
  • Reimbursement of $110-$140 (Medicare)
  • Any staff member easily trained
  • A simple handheld device producing more objective readings than traditional methods. Using temperature and vibration to assess small and large fiber nerves, the DND is non-invasive, quick, and painless.

3. CMWL Program

  • $10K-$40K additional monthly revenue
  • $175-$225 reimbursement screening
  • $100-$120 reimbursement follow-up visit
  • The most effective way to treat Type 2 Diabetes is to help your patient safely and effectively lose weight. The CMWL ObesityTx screening and treatment system allows you to seamlessly integrate a non-surgical medical weight loss platform into your practice to deliver evidence-based obesity care.

Download Now

Sponsored by:

The Center for Medical Weight Loss